12-month Prevalence Of Depression Research Articles

Depressionen und damit assoziierte Faktoren bei Rettungskräften in Deutschland – Ergebnisse aus der EMS-Health-Studie für den Zeitraum 2020/2021

Depression and associated factors among emergency medical services staff in Germany: results from the EMS Health Study for the period 2020/2021 Background: Depression is one of the most common psychological conditions and factors such as pain and psychosocial workload can increase the risk for depression. Since there is little data available for prehospital emergence medical services (EMS) staff in Germany, the aim of the study was to identify factors associated with depression. Methods: This analysis was a nationwide cross-sectional study with prehospital EMS staff in Germany. Factors associated with depression were identified using multivariable logistic regression analysis, calculating adjusted odds ratios (AOR) and associated 95 % confidence intervals (95 % CI). Results: A total of 2,313 EMS staff were included in the analysis. The 12-month prevalence of depression was 15.6 % in women and 12.2 % in men. Significantly associated with depression were qualifications (paramedic*s: AOR: 1.99 [95 % CI: 1.10; 3.58] p = 0.022; paramedic*s: AOR: 1.69 [95 % CI: 1.08; 2.61] p = 0.021; reference: paramedics) and actual working hours (increase per hour: AOR: 1.02 [95 % CI: 1.00; 1.03] p = 0.013). Furthermore, poorer health, severe pain, allergies, and being a former smoker were also associated with a significantly higher chance of depression. In contrast, employees living in a relationship showed a lower chance of suffering from depression. Conclusion: This analysis provides evidence for factors associated with depression in prehospital EMS staff in Germany. Keywords: mental health – rescue service – workload – rescue service personnel – paramedics

12-Monats-Prävalenz ausgewählter Erkrankungen bei Ärztinnen und Ärzten in Deutschland

12-month prevalence of selected diseases in physicians in Germany. Results of a cross-sectional study Objectives: The aim of this study was to evaluate the health status of physicians in Germany based on the 12-month prevalence of selected diseases, the BMI and their health behaviour. Methods: A cross-sectional study was conducted as an online survey using questions from the GEDA study. The 12-month prevalence of the selected diseases and the percentage proportion by BMI category and associated 95% confidence intervals (95% CI) were calculated. Results: A total of 343 physicians (73.18% women, 25.36% men, 1.46% non-binary) with a mean age of 37.77 (SD 8.42) years were included in this study. Based on BMI, 21.90% (95% CI: 16.86%; 27.65%) of female and 13.75% (7.07%; 23.27%) of male participants were found to be overweight. The highest 12-month prevalence was found for neck complaints (46.94% [95% CI: 41.58%; 52.37%]), back complaints (43.73% [95% CI: 38.41%; 49.16%] and allergies (34.69 [95% CI: 29.66%; 39.99%]). It should be noted here that the 12-month prevalence of depression among female participants was 13.55% (95% CI: 9.57%; 18.41%). 26.69% (95% CI: 21.96%; 31.84%) of participants exercised for ≥10 min never or less frequently than one day per week. In addition, 46.63% (95% CI: 41.11%; 52.20%) consulted a general practitioner/family doctor in the last 12 months. Conclusion: Overall, the participating physicians indicated a good health status, although the 12-month prevalence of depression in female participants could be considered high. Keywords: chronic diseases – health – medical staff – health behavior – 12-months prevalence

What Proportion of Patients With Musculoskeletal Sarcomas Demostrate Symptoms of Depression or Anxiety?

What Proportion of Patients With Musculoskeletal Sarcomas Demostrate Symptoms of Depression or Anxiety?

Prevalence of major depression and associated correlates in Latvian primary care population: results from the National Research Program BIOMEDICINE 2014–2017

Purpose and aim. In Latvia, the 12-month prevalence of depression in the general population has been estimated at 7.9%, but the data of the National Health Service show that general practitioners (GP's) saw only 3514 unique patients with a diagnosis of mood disorders in 2014. This is the first study conducted at the national level that was aimed to estimate the point and lifetime prevalence of depression and associated factors in primary care settings in Latvia.Materials and methods. This study was conducted at 24 primary care facilities in 2015. During a 1-week period, all consecutive adult patients were invited to complete the study questionnaires. Within a period of 2 weeks, the respondents were interviewed over the phone using the Mini International Neuropsychiatric Interview (M.I.N.I.), Version 6.0.0. A hierarchical multivariate data analysis was performed.Results. The study population consisted of 1485 patients. According to the M.I.N.I., 28.1% (95% CI 25.9–30.4) of the patients had at least one depressive episode in the past, and 10.2% (95% CI 8.7–11.8) had current depression. In the final multivariate analysis model, current major depression was associated with the female gender (OR 2.01), basic or unfinished basic education (OR 1.86), loss of marital ties (OR 1.86), and gastrointestinal (OR 3.46) and oncological (OR 2.26) diseases as a reason for visiting the GP.Conclusions. The prevalence of major depression in primary care is consistent with that in other European countries but is significantly underdiagnosed. Enhanced training in Latvian primary care settings may improve clinical outcomes.

Urbanicity of residence and depression among adults 50 years and older in Ghana and South Africa: an analysis of the WHO Study on Global AGEing and Adult Health (SAGE)

ABSTRACTObjectives: As the primary cause of disability worldwide, depression is a significant contributor to global morbidity and mortality and often disproportionately affects older adults. Several studies have demonstrated a link between urban residence and depression, but few studies have examined this association among older adult populations, and even fewer have studied it within an African context. Given that African societies are aging and urbanizing at rapid rates, this study aimed to assess the relationship between urbanicity and depression within older adult populations in two African countries.Method: Data were drawn from the Ghana and South Africa samples of the World Health Organization Study on Global AGEing and Adult Health (SAGE) wave 1 (2007–2008). Depression over the past 12 months was measured using self-reported treatment and depressive symptoms based on ICD-10 criteria in 4209 Ghanaian and 3148 South African adults aged 50 years and older residing in their current location for over one year.Results: The 12-month prevalence of depression was 7.5% and 4.0% in Ghana and South Africa, respectively; 41.1% and 65.6%, respectively, lived in urban areas. Comparing urban to rural residents, the adjusted odds ratio (OR) for depression in multivariable analysis was 1.13 (95% CI: 0.71–1.79) in South Africa and 0.85 (95% CI: 0.55–1.31) in Ghana.Conclusion: Results do not support a significant urban-rural difference in 12-month depression among Ghanaian or South African SAGE participants. Mental health resources in rural areas should therefore be enhanced in these countries for more equitable distributions between the two settings given similar need.

The Association Between Smoking Status and Depression in the General Population of Latvia

Introduction Tobacco dependence is the most common substance use disorder in people with mental illness. Smoking and depression are firmly associated and both represent major health problems. Aim The aim of the study was to assess association between smoking status and 12-months depression in representative sample of the general Latvian population. Methods The study was a part of health monitoring survey, a collaborative project between Baltic States and Finland, which monitors health related behaviours; the questionnaire included structured interview and depressive module of the Mini International Neuropsychiatric Interview. Descriptive statistics and binary regression model were applied. Results A total of 3003 15-64 years old persons were interviewed by using face-to-face data collection tool. The 12-month prevalence of depression in the general population of Latvia was 7.3% (95% CI 6.4–8.3). Of those who were current smokers the 12-months prevalence of depression comprised 9.8% (95% CI 8.0–11.8), in occasional smokers 12.7% (95% CI 8.1–19.5), in quitters and non-smokers population – 6.6% (95% CI 4.6–9.4) and 6.4% (95% CI 5.3–7.8), accordingly. Current smokers had 2.0 times (95% CI 1.4-2.8; p Conclusions Clinical evaluationson presence of depression for all patients who smoke are needed. Further population-based studies are necessary to determine the causal effects between smoking and depression.

Chronic and treatment resistant depression: diagnosis and stepwise therapy.

The 12-month prevalence of depression in Europe is approximately 7%; depression becomes chronic in 15-25% of sufferers. One-third to one-half do not respond to an initial trial of drug therapy lasting several weeks. Selective literature review, including consideration of the German National Disease Management Guideline Unipolar Depression. At the end of an initial trial of treatment with an antidepressant drug, usually lasting four weeks, its efficacy should be evaluated systematically. In case of non-response, the following options have been found useful: measurement of the serum drug level, dose escalation (but not for selective serotonin reuptake inhibitors [SSRIs]), lithium augmentation, the addition of a second-generation antipsychotic (atypical neuroleptic), and any one of several defined combinations of antidepressants. There is no empirical evidence for switching to another antidepressant. Electroconvulsive therapy is the most effective treatment for refractory depression. Cognitive behavioral therapy, interpersonal psychotherapy, psychoanalysis and psychodynamic psychotherapy have also been found useful. The cognitive behavioral analysis system of psychotherapy (CBASP) was developed specifically for the treatment of chronic depression. The structured application of treatments of documented efficacy, in a stepwise treatment algorithm that gives equal weight to drugs and psychotherapy, is the best way to prevent or overcome treatment resistance and chronification.

EPA-1513 - Utilization of health care among people with depression in Latvia

Depression is highly prevalent and disabling mental disorder, less than one third of all cases receive any treatment, suggesting a remarkable level on unmet needs. The aim of the study was to assess differences in health care utilization among people with depression and those with no symptoms in representative sample of the general Latvian population. The study was a part of the FINBALT health monitoring survey in 2012, a collaborative project between Baltic States and Finland, which monitors health related behaviours; the questionnaire included depression module of the Mini International Neuropsychiatric Interview (MINI). A total of 3003 15-64 years old persons were interviewed by using face-to-face computerized data collection tool. The 12-month prevalence of depression in the general population of Latvia was 7.3% (95% CI 6.4–8.3). Use of any health care service over last 12 months was higher among those with depression compared with those without symptoms (84.8% and 73.1%); these differences remained significant after adjusting for age and gender (OR=2.0; 95% CI 1.4–3.0; p<0.001). Primary care services were used 4.3 times (SD 3.0) during the last 12 months among those with depression as compared with 3.2 (SD 3.9) times among those with no depression (t=4.50; p<0.001); while specialist services were used 3.1 times (SD 2.5) and 2.4 times (SD 1.8)(t=-3.973, p<0.001), respectively. Health care services are more frequently sought-after by people with depression, and taking into account underdiagnosis of depression in Latvia, more efficient screening and management tools are needed.

Fingolimod (Gilenya(R)) in Combination with an SSRI or SNRI Antidepressant in Multiple Sclerosis Patients with Mild to Moderate Depression: Design of a Phase IIIb Study (REGAIN) (P01.135)

Objective: The primary endpoint is the safety and tolerability profile of the combination of an SSRI or SNRI antidepressant with fingolimod in MS patients (expanded disability status scale (EDSS) 0–6.5) who are suffering mild to moderate depression (BDI-II 14-28). In addition, the efficacy of the combination therapy on quality of life, treatment satisfaction and other MS related sequelae will be exploratively assessed. Furthermore, in terms of health economics, the MS-specific and depression-specific use of resources will be evaluated. Background Almost half of all patients with multiple sclerosis (MS) are affected by concomitant psychological diseases, depression being most frequent (46%). The 12-month prevalence of depression in MS patients is 26%, which is three times higher than in the general population. Although some studies have shown a positive effect of selective serotonin/noradrenaline or serotonin re-uptake inhibitors (SNRIs or SSRIs, respectively), there is currently no established drug treatment of depression in MS patients. Therefore, in this open-label study, the safety and tolerability of the combination of fingolimod and an SSRI or SNRI antidepressant will be investigated in MS patients with mild to moderate depression. Design/Methods: In the REGAIN study ( R educe d E pression with G ilenya A nd SNRI/SSRI ant I depressant in MS-patie N ts) 375 patients with relapsing remitting MS and a mild to moderate depression, will be included. Patients will be pre-treated for 2 weeks with fingolimod, followed by a 16-week concomitant antidepressant treatment phase, with either an SSRI or an SNRI (Citalopram, Fluoxetine or Venlafaxine), at the discretion of the investigator, while maintaining on fingolimod therapy. After 8 and 16 weeks, the safety and tolerability of the combination therapy will be assessed. Results: Baseline demographics will be available in April 2012. Conclusions: This study will provide first-time data on the safety and tolerability of a combination therapy of fingolimod and an SSRI or SNRI antidepressant in MS patients with mild to moderate depression. Supported by: Novartis Pharma GmbH; Germany. Disclosure: Dr. Schuh has received personal compensation for activities with Novartis as an employee. Dr. Meergans has received personal compensation for activities with Novartis as an employee. Dr. Bayas has received personal compensation for activities as a investigator.

P02-381 - Prevalence of depression among pregnant women seen in a public primary health service in rio de janeiro city

BackgroundDepression is the most prevalent psychiatric disorder during pregnancy and it is associated with psychosocial and clinical obstetric factors. Despite being an important Public Health issue, there are few studies about this subject in Brazil.AimThis study aimed to estimate the prevalence and risk factors for depression during pregnancy.MethodA Cross-sectional study of 331 pregnant women attending a public primary health service over a one-year period in Rio de Janeiro. Participants were interviewed about their socio-demographic status, obstetric/medical conditions, life events and violence during pregnancy. Depression was assessed through the Composite International Development Interview.ResultsThe 12-month prevalence of depression was 14.2% (CI 95% 10.7 - 18.5) and associated factors were: previous history of depression and any psychiatric treatment, unplanned pregnancy, serious physical illness and casual jobs.ConclusionThese data emphasize the need for screening for depression and its risk factors during pregnancy in settings where care is available. Psychosocial interventions and social policies need to be implemented in this population

The specific burden of comorbid anxiety disorders and of substance use disorders in bipolar I disorder

Uncertainty exists regarding whether comorbid substance use disorders (SUDs) in bipolar I disorder are more prevalent among persons with versus without comorbid anxiety disorders. Moreover, the independent contribution of these comorbidities to the burden of bipolar disorder (BD) is unclear. The 2001-2002 National Epidemiologic Survey on Alcohol and Related Conditions was used to identify respondents with lifetime BD (n = 1,411). Illness severity was compared across four groups based on the presence of lifetime anxiety disorders, lifetime SUDs, neither, or both. Variables included lifetime prevalence of mixed mania, prolonged mood episodes, BD-related health service utilization, and forensic history, 12-month prevalence of mania and depression, and current general mental health functioning. Diagnoses were generated using the National Institute on Alcohol Abuse and Alcoholism Alcohol Use Disorder and Associated Disabilities Interview Schedule, DSM-IV Version. Analyses were computed separately for males and females. For females only, the lifetime prevalence of SUDs was significantly greater among those with lifetime anxiety disorders [odds ratio (OR) = 1.41, 95% confidence interval (CI) = 1.08-1.86]; this was not found among males (OR = 1.15, 95% CI = 0.79-1.68). In multiple logistic regression analyses among both males and females, anxiety disorders were significantly associated with mixed episodes, prolonged depressive episodes, 12-month prevalence of depression, BD-related health service utilization, and poorer current mental health functioning. SUDs were significantly associated with mixed episodes among females, 12-month prevalence of depression among males, and with forensic history among both males and females. Whereas comorbid anxiety disorders appear to confer increased liability towards poor mental health functioning and greater BD-related health service utilization, comorbid SUDs are associated with positive forensic history. Early identification and treatment of these comorbid conditions are of paramount importance. Further representative prospective studies are needed.

Poverty, violence and depression during pregnancy: a survey of mothers attending a public hospital in Brazil

Depression in women is associated with social deprivation and violence. We describe the prevalence and risk factors for depression during pregnancy, in particular the association with poverty and violence, in a Brazilian setting. A cross-sectional survey of women in the third trimester of pregnancy attending a public hospital maternity clinic from August 2003 to July 2004 in Rio de Janeiro. Participants were interviewed about their sociodemographic status, obstetric and medical conditions, substance use, stressful life events, and social support. Depression was diagnosed through the Composite International Diagnostic Interview (CIDI). A total of 230 of 240 eligible women consented to participate. The 12-month prevalence of depression was 19.1% (95% CI 14.4-24.9). On multivariate analyses, having been educated beyond primary school was protective (OR 0.5, 95% CI 0.2-0.9). Risk factors were: being divorced or widowed (OR 4.9, 95% CI 1.3-18.3); a history of depression before pregnancy (OR 7.9, 95% CI 3.1-20.5); loss of an intimate relationship (OR 8.4, 95% CI 3.3-21.4), experienced financial difficulties (OR 6.6, 95% CI 2.5-17.2) and having been exposed to violence in the previous year (OR 4.2, 95% CI 1.5-11.8). Depression is common during pregnancy and is associated with indicators of socio-economic deprivation, violence and the loss of an intimate relationship, and with a previous history of depression. Psychosocial interventions and appropriate social policies need to be implemented in this population to reduce the burden of maternal depression.

12-month prevalence of depression among single and married mothers in the 1994 National Population Health Survey.

While a number of studies have documented higher period prevalence rates of depression among single as compared to married mothers, all of the data have been based upon community surveys of mental illness. In Canada, all of the published work comes from Ontario. As a result, we do not know whether these results hold true for other regions of the country. Using a nationally representative sample, we find, consistent with previous work, that single mothers have almost double the 12-month prevalence rates of married mothers (15.4% versus 6.8%). As well, there are no significant differences in rates of depression between single and married mothers by region/province of the country. Our findings are compared with other epidemiologic data on the mental health of single mothers from Ontario.

12-Month Prevalence of Depression Among Single and Married Mothers in the 1994 National Population Health Survey

While a number of studies have documented higher period prevalence rates of depression among single as compared to married mothers, all of the data have been based upon community surveys of mental illness. In Canada, all of the published work comes from Ontario. As a result, we do not know whether these results hold true for other regions of the country. Using a nationally representative sample, we find, consistent with previous work, that single mothers have almost double the 12-month prevalence rates of married mothers (15.4% versus 6.8%). As well, there are no significant differences in rates of depression between single and married mothers by region/province of the country. Our findings are compared with other epidemiologic data on the mental health of single mothers from Ontario.